Skip to main content
. Author manuscript; available in PMC: 2015 Aug 24.
Published in final edited form as: Bone Marrow Transplant. 2012 Mar 5;47(10):1377–1378. doi: 10.1038/bmt.2012.33

Table 1.

Characteristics of the study population of 20 surviving ALD patients with testing for adrenal insufficiency 1 - 7 years post transplantation

Variable Adrenal function (pre-HCT/post-HCT)
abnormal/abnormal normal/abnormal normal/normal
N 16 3 1
Age at HCT (years), mean±s.d. 7.9±2.3 10.1±0.2 8.3
Years between HCT and ACTH stimulation test mean±s.d. (range) 2.5±2.1 (1 - 7) 1.6±0.6 (1 - 2) 4 (NA)
Peak stimulated cortisol level (mg/dL) post HCT mean±s.d. 4.0±5.3 12.4±3.4 21.2
Currently on hydrocortisone (N, %) 16 (100%) 3 (100%) 0 (0%)
Currently on fludrocortisone (N, %) 9 (56%) 3 (100%) 0 (0%)
Donor type (N)
 Cord blood 7 2 0
 Related marrow 7 1 1
 Unrelated marrow 2 0 0
Conditioning (N)
 Myeloablative 12 2 0
 Non-myeloablative 4 1 1

Abbreviations: ACTH=adrenocorticotropic hormone; ALD=adrenoleukodystrophy; HCT=hematopoietic cell transplantation; NA=not available.